1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Summary of complication and cure rates in recent larger series with embolization predominantly or exclusively using Onyx
Series No. of Patients Permanent Morbidity and Mortality (%) Cure by Embolization Alone (%) Mounayer et al3 94 11 (11.7) 26 (28)* Weber et al5 93 9 (9.7) 19 (20.4) Katsaridis et al7 101 11 (10.9) 28 (27.7)* Pierot et al2 48 6 (12.5) 2 (4.1)* van Rooij et al6 44 3 (6.8) 7 (15.9) Perez-Higueras et al8 45 8 (17.7) 10 (22.2) Panagiotopoulos et al1 82 9 (11.3) 16 (19.5)
* Further endovascular treatment was planned in some patients.